DAM
BMY icon

DLD Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

DLD Asset Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$432K Buy
+7,500
New +$431K 0.03% 265
2025
Q4 		– Sell
-183,400
Closed -$8.27M – 390
2025
Q3 		$8.27M Buy
+183,400
New +$8.57M 0.6% 36

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DLD Asset Management's BMY Position: Q4 2025 in Review

DLD Asset Management sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 12,827 shares — an estimated $578K sold.

DLD Asset Management first reported a position in BMY in Q3 2025 and held it in 1 quarter. The position peaked at $578K in Q3 2025. 2,456 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • DLD Asset Management reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • DLD Asset Management sold 12,827 Bristol-Myers Squibb shares in Q4 2025, an estimated $578K.
  • DLD Asset Management first reported a position in Bristol-Myers Squibb in Q3 2025 and held it in 1 quarter.
  • DLD Asset Management's Bristol-Myers Squibb position peaked at $578K in Q3 2025.
  • 2,456 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.